Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Providence Tarzana Surgeon First In U.S. To Use New State-of-the-Art Imaging Tool
Providence Tarzana Medical Center on Friday became the first. hospital in the nation to use the latest generation in imaging - the Ziehm Vision RFD - in this case to aid a surgeon in opening the clogged carotid artery of a patient who had suffered a small stroke.
generic viagra online
Young People At High HIV Risk Say Peers Should Teach Prevention
African-American adolescents have some of the highest rates of HIV infection in the United States, and efforts to educate them about preventing the disease must include the help of their adolescent peers, new research suggests.
News of the day
Labs Are Vital™ Announces Winners Of 2009 National Video Contest To Highlight Careers In Lab Sciences
Labs Are Vital™ announced that a 2009 high school graduate from northern California, Kelly Peterson, is the grand prize winner of its national video contest. High school students around the country submitted their views on video about why careers in the clinical lab sciences are vital.
Public Health

OncoGenex Pharmaceuticals To Webcast ASCO Reception On May 30, 2009

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that the Company will hold a live webcast and conference call of presentations made at an OncoGenex hosted reception during the 2009 American Society of Clinical Oncology Annual Meeting (ASCO) on Saturday, May 30, 2009. The webcast will begin at 7:10 p.m. EDT. During the reception, OncoGenex management and guest speakers will provide a comprehensive review of the final results of a randomized Phase 2 trial presented during an oral presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting, as well as discuss the treatment landscape and the relevance of clinical trial endpoints for prostate cancer. Guest speakers include: - Dr. Kim Chi, OGX-011 Principal Investigator, BC Cancer Agency - Dr. Oliver Sartor, Medical Oncologist, Tulane Medical School - Dr. Tomasz Beer, Medical Oncologist, Oregon Health & Science University - Dr. Brent Blumenstein, Independent Statistician, Trial Architecture Consulting - Dr. Martin Gleave, Distinguished Professor, Department of Urologic Sciences, University of British Columbia and Chief Scientific Officer, OncoGenex Pharmaceuticals, Inc. To access the webcast, log on to the Investor Relations page of the OncoGenex Web site at http://www.oncogenex.com. Alternatively, you may access the live conference call by dialing 877-627-6544 (U.S. & Canada) or 719-325-4857 (International). A webcast replay will be available approximately two hours after the call and will be archived at http://www.oncogenex.com. OncoGenex Pharmaceuticals


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009